Skip to main content
. 2023 Aug;51(8):923–935. doi: 10.1124/dmd.122.001005

TABLE 4.

IC50 values for mitragynine and kratom extracts against P450 and UGT activities using various test systems

Enzyme Substrate Reaction Enzyme System Monitoring Method Mitragynine (μM) Extract (μg/ml)
CYP1A2 phenacetin O-deethylation HLMs LCMS >45
CEC O-deethylation recombinant fluorometric 39
CYP2C8 amodiaquine N-deethylation HLMs LCMS 33.5
CYP2C9 diclofenac 4’-hydroxylation HLMs LCMS >45
luciferin H 9.7
diclofenac 4’-hydroxylation HLMs LCMS 39.7
CYP2C19 S-mephenytoin 4’-hydroxylation HLMs LCMS 10.5
CEC O-deethylation recombinant fluorometric 85
CYP2D6 dextromethorphan O-demethylation HLMs LCMS 2.2
AMMC O-demethylation recombinant fluorometric 0.64
luciferin ME-EGE luminometric 0.45
luciferin ME-EGE luminometric 3.6
dextromethorphan O-demethylation HLMs LCMS 0.67
CYP3A4/5 Midazolam 1’-hydroxylation HLMs LCMS 11.4
testosterone 6β-hydroxylation HLMs LCMS >45
BFC O-debenzylation recombinant fluorometric 0.78
midazolam 1’-hydroxylation recombinant HPLC-UV 17.31
testosterone 6β-hydroxylation recombinant HPLC-UV 3.98
luciferin-BE luminometric 41.32
luciferin-BE luminometric 142.8
midazolam 1’-hydroxylation HLMs LCMS 18.9
midazolam 1’-hydroxylation HIMs LCMS 21.9
UGT1A1 4-MU glucuronidation recombinant HPLC-UV >100
UGT2B7 zidovudine glucuronidation HLMs HPLC-UV 8.11
4-MU glucuronidation recombinant HPLC-UV >100

—, information not available.

AMMC, 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin; BFC, 7-benzyloxy-4-(trifluoromethyl)-coumarin; CEC, 3-cyano-7-ethoxycoumarin; HPLC-UV, high pressure liquid chromatography coupled with UV detector; luciferin-BE, luciferin 6’ benzyl ether; luciferin H, 6’deoxyluciferin; luciferin ME-EGE, ethylene glycol ester of luciferin 6’ methyl ether; 4-MU, 4-methylumbelliferone.